Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal
1 other identifier
interventional
398
1 country
1
Brief Summary
Hypertension (HTN) and diabetes mellitus are significant global public health challenges, contributing to 13.5% of premature deaths, 54% of incident strokes, and 47% of coronary heart disease cases (HTN), and increasing risks of cardiovascular diseases, kidney failure, and other complications (diabetes). In Nepal, HTN prevalence is 24.5% and diabetes affects 5.8% of adults (2019 Nepal STEPS Survey), with many cases undiagnosed or poorly managed, and an estimated 60% co-morbidity among diabetic individuals. Nepal's Package of Essential Non-Communicable Diseases (PEN), implemented since 2017, targets both conditions, but multi-level barriers limit its facility-based effectiveness. This study addresses the need for cost-effective, evidence-based strategies for HTN and diabetes management in low-resource settings, focusing on marginalized populations. It proposes a Type II hybrid implementation-effectiveness study with two objectives: (1) evaluate implementation outcomes (reach, adoption, implementation, maintenance) of the Female Community Health Volunteers (FCHVs)-led integrated HTN and diabetes management using the RE-AIM framework; (2) assess effectiveness compared to facility-based PEN on systolic blood pressure and fasting blood sugar at 12 months. FCHVs will deliver integrated health education, form peer groups, and coordinate care. Using a mixed-method approach, the study involves a cluster randomized controlled trial with participants, collecting quantitative data on implementation, supplemented by in-depth interviews (8-16 patients) and focus group discussions (2 FGDs with FCHVs), with qualitative tracking logs. The intervention adapts a prior FCHV-led HTN trial to integrate diabetes management. FCHVs will receive 3-day training on screening, counseling, BP and blood sugar monitoring, and referrals for both conditions. Mass screening will identify HTN and diabetes cases, forming monthly FCHV groups for lifestyle counseling, BP, and glucose tracking, with family involvement. Monthly referrals will link uncontrolled cases to facilities. This aims to enhance integrated HTN and diabetes management, fostering community engagement and healthcare coordination, with findings to inform scalable NCD strategies in Nepal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 14, 2025
CompletedFirst Submitted
Initial submission to the registry
January 27, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
March 10, 2026
March 1, 2026
1.9 years
January 27, 2026
March 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Reach
The proportion of the target population that participates in the intervention.
12 months
Adoption
The proportion of health facilities that are willing or are adopting the group-care intervention. Minutes of consultative meetings between investigating team and health facility in-charges will provide evidence of the adoption by the health facilities.
12 months
Implementation
The proportion of extent to which the FCHV-led intervention is delivered as intended. This will be measured using observation checklist.
12 months
Mean systolic blood pressure (BP) (mmHg)
The net change in mean systolic BP between intervention and control.
12 months
Mean glycated hemoglobin (%)
The net change in mean hba1c levels between intervention and control group.
12 months
Secondary Outcomes (5)
Physical activity
12 months
Anti hypertension Medication adherence
12 months
Anti-diabetic medicine adherence
12 months
Hypertension knowledge
12 months
Diabetes knowledge
12 months
Study Arms (2)
'Group Care' arm
EXPERIMENTALFCHVs will under 3 days trainings and conduct group care session in collaboration with health care workers from health facilities during the outreach clinics (ORC) and conduct home visit to those people who are unable to join the group care session. The FCHVs will maintain registry of the patients under the group care and log their blood pressure and blood sugar.
Regular Facility-based Care Arm
NO INTERVENTIONThe participants in the control arm will receive the regular health facility based care from the health facilities. They will not receive any group care sessions.
Interventions
FCHVs will undergo a 3-day training program on HTN and DM management, including screening, counseling, medication adherence, self-care, and referrals. They will then collaborate with healthcare facilities to conduct one-day hypertension screening camps(outreach clinics). FCHVs will form groups for individuals with hypertension and hold monthly meetings 1-3 days prior to outreach clinic by health facilities to discuss control strategies, review BPlogs, and promote healthcare visits, including family involvement identify uncontrolled and refer to outreach clinics. They will also conduct home visits to those who are not able to join the group care session and also maintain regular communication with health facilities.
Eligibility Criteria
You may qualify if:
- years or older
- have a high blood pressure of 140/90 mmHg or under hypertension medication
- have a high blood sugar of 6.5% or more (hba1c) or under diabetes medication are able to provide informed consent
You may not qualify if:
- any form of disabilities limiting participation in the study
- severe illness requiring bed rest, and
- pregnant women, due to their special health needs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Implementation Science and Health
Kavre, Bagmati, Nepal
Related Publications (13)
Evans J, Ha H, White PT. Evaluating the effectiveness of community health worker interventions on glycaemic control in type 2 diabetes mellitus: a systematic review and meta-analysis. BMJ Open. 2025 Jul 15;15(7):e096651. doi: 10.1136/bmjopen-2024-096651.
PMID: 40664405BACKGROUNDKim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000 Summer;15(3):90-6. doi: 10.1111/j.1751-7117.2000.tb00211.x.
PMID: 10951950BACKGROUNDHan HR, Chan K, Song H, Nguyen T, Lee JE, Kim MT. Development and evaluation of a hypertension knowledge test for Korean hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct;13(10):750-7. doi: 10.1111/j.1751-7176.2011.00497.x. Epub 2011 Jul 14.
PMID: 21974763BACKGROUNDAryal KK, Mehata S, Neupane S, Vaidya A, Dhimal M, Dhakal P, Rana S, Bhusal CL, Lohani GR, Paulin FH, Garg RM, Guthold R, Cowan M, Riley LM, Karki KB. The Burden and Determinants of Non Communicable Diseases Risk Factors in Nepal: Findings from a Nationwide STEPS Survey. PLoS One. 2015 Aug 5;10(8):e0134834. doi: 10.1371/journal.pone.0134834. eCollection 2015.
PMID: 26244512BACKGROUNDMurray LK, Dorsey S, Bolton P, Jordans MJ, Rahman A, Bass J, Verdeli H. Building capacity in mental health interventions in low resource countries: an apprenticeship model for training local providers. Int J Ment Health Syst. 2011 Nov 18;5(1):30. doi: 10.1186/1752-4458-5-30.
PMID: 22099582BACKGROUNDGearing RE, El-Bassel N, Ghesquiere A, Baldwin S, Gillies J, Ngeow E. Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation. Clin Psychol Rev. 2011 Feb;31(1):79-88. doi: 10.1016/j.cpr.2010.09.007. Epub 2010 Oct 7.
PMID: 21130938BACKGROUNDJindal D, Sharma H, Gupta Y, Ajay VS, Roy A, Sharma R, Ali M, Jarhyan P, Gupta P, Srinivasapura Venkateshmurthy N, Ali MK, Narayan KMV, Prabhakaran D, Weber MB, Mohan S, Patel SA, Tandon N. Improving care for hypertension and diabetes in india by addition of clinical decision support system and task shifting in the national NCD program: I-TREC model of care. BMC Health Serv Res. 2022 May 23;22(1):688. doi: 10.1186/s12913-022-08025-y.
PMID: 35606762BACKGROUNDLabhardt ND, Balo JR, Ndam M, Grimm JJ, Manga E. Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two years. BMC Health Serv Res. 2010 Dec 14;10:339. doi: 10.1186/1472-6963-10-339.
PMID: 21144064BACKGROUNDSun Y, Mu J, Wang DW, Ouyang N, Xing L, Guo X, Zhao C, Ren G, Ye N, Zhou Y, Wang J, Li Z, Sun G, Yang R, Chen CS, He J; CRHCP Study Group. A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial. Lancet. 2022 May 21;399(10339):1964-1975. doi: 10.1016/S0140-6736(22)00325-7. Epub 2022 Apr 29.
PMID: 35500594BACKGROUNDGyawali B, Sharma R, Neupane D, Mishra SR, van Teijlingen E, Kallestrup P. Prevalence of type 2 diabetes in Nepal: a systematic review and meta-analysis from 2000 to 2014. Glob Health Action. 2015 Nov 26;8:29088. doi: 10.3402/gha.v8.29088. eCollection 2015.
PMID: 26613684BACKGROUNDHaider MR, Das Gupta R. Inequalities in undiagnosed hypertension among adult Nepalese population: Evidence from a nationally representative survey. Int J Cardiol Hypertens. 2020 Mar 15;5:100026. doi: 10.1016/j.ijchy.2020.100026. eCollection 2020 Jun.
PMID: 33447755BACKGROUNDPetrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018 May;34(5):575-584. doi: 10.1016/j.cjca.2017.12.005. Epub 2017 Dec 11.
PMID: 29459239BACKGROUNDMendis S, O'Brien E, Seedat YK, Yusuf S. Hypertension and diabetes: entry points for prevention and control of the global cardiovascular epidemic. Int J Hypertens. 2013;2013:878460. doi: 10.1155/2013/878460. Epub 2013 Apr 7. No abstract available.
PMID: 23653856BACKGROUND
Related Links
- IDF Diabetes Atlas 2015 (PDF) - 7th Edition (International Diabetes Federation)
- Diabetes and Hypertension Evaluation and Management
- Package of Essential Non-communicable Diseases (PEN) \[Internet\]. Package of Essential Non-communicable Diseases (PEN). \[cited 2022 Sep 25\].
- Global Diet Quality Project - Diet Quality Questionnaire (DQQ) Tools \& Data
- WHO - Global Physical Activity Questionnaire (GPAQ) Analysis Guide, 2012
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Archana Shrestha, PhD
Kathmandu University School of Medical Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 27, 2026
First Posted
February 25, 2026
Study Start
December 14, 2025
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
March 10, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share